Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BMS’s Opdivo On Track For Esophageal Cancer Indication

Oct 01 2019

• By Sten Stovall

Esophageal cancer — Opdivo Extended Overall Survival In ATTRACTION-3 Trial Versus Chemo • Source: Shutterstock

Additional Topics

ImmunoOncology Clinical Trials Commercial Companies Research & Development Cancer BioPharmaceutical

More from Immuno-oncology

More from Anticancer

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.